Pacira BioSciences faces significant risk as generic challenges threaten Exparel, its flagship product responsible for 78% of 2024 revenue. PCRX's complex formulation, robust patent estate, and ...
The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...
Jamie Dimon is right to be alarmed about our national-security vulnerabilities, especially an overreliance on China and India for generic prescription drugs (“Investments for National Security,” op-ed ...
Jack Peachey is a features writer who's worked at Dualshockers and Game Rant. An animation nerd, his favourite games don't have a genre in common as much as they all have pretty pictures. When not ...
A number of teams (and their fanbases) have already turned their attention towards the offseason. Identifying free agent targets is a big part of that prep work, so it’s worth taking a look at the ...
As you already know, the Mercedes A-Class and B-Class are dying for good at the end of their current generations. The compact minivan will be put to sleep in 2026 after three generations, and the ...
AbbVie settles with generic Rinvoq hopefuls, shielding the immunology med's US stronghold until 2037
With Rinvoq and its sibling medicine Skyrizi having successfully picked up the sales torch in the wake of Humira’s tumble over the patent cliff, AbbVie is working to cover its legal bases so the ...
Medications are rarely made from start to finish in a single country; raw materials, active ingredients and final products often cross multiple borders before reaching patients in the U.S., The New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback